Eve Holding Q3 Loss Widens to $58.1M; Liquidity $470.4M, Equity Turns Negative
EVEX sits 20% above its 52-week low of $1.405.
Summary
Eve's Q3 net loss widened to $58.1 million on higher R&D, while total debt jumped to $322.1 million and equity turned negative; management cites about $470.4 million of total liquidity, enough for at least twelve months.
Key Events · Earnings and Guidance · EVEX
-
Q3 Loss Widens on R&D
Net loss was $58.1 million versus $46.9 million a year earlier; R&D rose to $48.3 million from $44.9 million and SG&A fell to $6.0 million from $7.0 million.
-
Debt Nearly Doubles
Total debt, net reached $322.1 million at September 30, 2026 from $179.8 million at December 31, 2025, including $150.0 million drawn under the January 2026 syndicated credit agreement; interest expense rose to $15.4 million for nine months from $7.3 million.
-
Equity Turns Negative
Total equity was $(34.5) million versus $123.8 million at year-end 2025, with the accumulated deficit at $868.2 million.
-
Liquidity Covers Twelve Months
Management cites approximately $470.4 million of total liquidity — $127.6 million cash and restricted cash, $228.4 million investments, $104.2 million undrawn debt and $10.2 million Finep grant commitments — sufficient for at least the next twelve months.
Analysis · EVEX · Manufacturing
The headline loss is already out, but the balance sheet is the real story: total debt nearly doubled to $322.1 million after the $150.0 million syndicated credit facility was drawn in January 2026, and stockholders' equity flipped to a $34.5 million deficit. Against that, management puts total liquidity at roughly $470.4 million — cash, restricted cash and investments of $355.8 million, $104.2 million of undrawn debt and $10.2 million of Finep grant commitments — and says that covers the operating plan for at least twelve months. With no revenue until commercialization targeted for 2028, the runway math and the rising interest bill ($15.4 million for nine months versus $7.3 million) are what determine whether another equity raise is needed.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVEX was trading at $1.68 on NYSE in the Manufacturing sector, with a market capitalization of approximately $585.5M. The 52-week trading range was $1.41 to $5.16. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.